Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Eledon Pharmaceuticals Inc (NASDAQ: ELDN) was $2.06 for the day, down -49.76% from the previous closing price of $4.1. In other words, the price has decreased by -$49.76 from its previous closing price. On the day, 29.57 million shares were traded. ELDN stock price reached its highest trading level at $2.15 during the session, while it also had its lowest trading level at $1.43.
Ratios:
Our analysis of ELDN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.12 and its Current Ratio is at 8.12. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 28, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELDN now has a Market Capitalization of 123356456 and an Enterprise Value of 72519344.
Stock Price History:
The Beta on a monthly basis for ELDN is 0.75, which has changed by -0.58467746 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, ELDN has reached a high of $5.17, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is -31.11%, while the 200-Day Moving Average is calculated to be -37.06%.
Shares Statistics:
ELDN traded an average of 1.22M shares per day over the past three months and 4837550 shares per day over the past ten days. A total of 59.88M shares are outstanding, with a floating share count of 55.84M. Insiders hold about 6.75% of the company’s shares, while institutions hold 63.63% stake in the company. Shares short for ELDN as of 1760486400 were 3515385 with a Short Ratio of 2.87, compared to 1757894400 on 5429434. Therefore, it implies a Short% of Shares Outstanding of 3515385 and a Short% of Float of 6.5600000000000005.
Earnings Estimates
. The current market rating for Eledon Pharmaceuticals Inc (ELDN) reflects the collective analysis of 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.17 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.49 and -$1.26 for the fiscal current year, implying an average EPS of -$0.85. EPS for the following year is -$1.12, with 4.0 analysts recommending between -$0.97 and -$1.31.
